(-)-Caryophyllene Oxide

(-)-Caryophyllene Oxide

SCHEMBL24110118

C=C1CC[C@H]2O[C@@]2(C)CC[C@@H]2[C@@H]1CC2(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 10/20 1.00
▸ FTH1 P02794 1/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ CYP2C19 P33261 1/20 1.00
▸ CNR2 P34972 2/20 0.51
▸ PPARA Q07869 2/20 0.51
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ PTPN1 P18031 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.40
▸ USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(-)-Caryophyllene Oxide SCHEMBL16489852 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL16769854 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL1532444 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL127077 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL17857878 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL24110084 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL676309 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL18788522 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL21349931 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2
(-)-Caryophyllene Oxide SCHEMBL26189380 1.00 CYP3A4 (1.00) CYP3A4FTH1CYP2C9CYP2C19CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387959-A1 PROCESS FOR PREPARING CARYOPHYLLENE OXIDE SYMRISE AG (DE) 2021-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387959-A1 PROCESS FOR PREPARING CARYOPHYLLENE OXIDE POR, SQLE, CBR3 CYP3A4 99/4885FTH1 845/4885CYP2C9 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback